
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.

October 11, 2023
Moving beyond static evidence development to ensure local market access success; responding to recent changes in...
Read article

August 28, 2023
How to Create and Optimize a Clinical Development Plan
A clinical development plan — a comprehensive strategy for developing an investigational product through regulatory...
Read article

February 1, 2021
February 2021: Updates from the CYTEL COVID-19 Trial Tracker
Cytel’s COVID-19 Trial Tracker continues to provide real time updates to the status of COVID-19 clinical trials...
Read article

January 11, 2021
COVID-19 Trial Tracker Updates (January 11)
In April 2020, Cytel launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater...
Read article

December 15, 2020
Satisficing, Optimizing and Globally Optimizing Trial Designs
When designing clinical trials, biostatisticians and clinical development teams are often faced with a conundrum. Given...
Read article

December 9, 2020
7 Key Features of Strategic Clinical Trial Design
As a part of Cytel’s Advanced Design Framework, a new Framework for the statistical design of clinical trials, Cytel...
Read article

December 3, 2020
New Whitepaper: Reimagining Clinical-Trials
Increasing Clinical Development Productivity Using Statistics and Cloud-Computing The need for Re-imagining Clinical...
Read article

November 18, 2020
We can design over 100,000 clinical trials in less than an hour
The current state of the clinical trials industry faces a challenge that was only hypothetical three or four years ago....
Read article

November 11, 2020
Interview with Yannis Jemiai: Advanced Design Framework
The widespread use of cloud-computing has altered the clinical trial design process. Whereas three or four years ago,...
Read article

November 4, 2020
Cytel Introduces Advanced Design Framework: Part 3 - Communication Techniques to Ensure Alignment on Data-Driven Clinical Trial Designs
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought leaders that draws on...
Read article

October 29, 2020
Advanced Design Framework: Part 2 - A Quantitative Evaluation Approach
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought leaders that draws on...
Read article

October 21, 2020
Advanced Design Framework: Part 1 - Exploration of Design Space
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought-leaders after a decade...
Read article

October 15, 2020
An Advanced Design Framework for Clinical Development in the Era of Cloud-Computing
For over a decade, advanced trial design techniques have promised efficient trials with accelerated timelines,...
Read article

August 18, 2020
Career Perspectives: Interview with Mrudula Joshi, Associate Director, Statistical Programming Services
Mrudula Joshi joined Cytel in July 2005 as a young SAS programmer. Last month, she celebrated her 15th year work...
Read article

July 11, 2020
COVID-19 Clinical Development Quiz (with Answers)
Last week we challenged you to take a COVID-19 Clinical Development Quiz. Many of you used our Trial Tracker to find...
Read article

April 7, 2020
Career Perspectives: Interview with Marc Lefebvre-Gouy, Statistical Programmer
Cytel has industry-leading experts in Statistical Programming with years of SAS® Programming expertise and in-depth...
Read article

March 5, 2020
Managing risk in clinical development: Is your data strategy fail-safe?
Generating high-quality clinical data is a vital but challenging task in modern drug development. Unfortunately, in the...
Read article

February 6, 2020
Is your data strategy set up to tackle key challenges in early clinical development?
In clinical development, a high-quality evidence package is a prerequisite for a new therapy to gain approval from...
Read article

January 30, 2020
Designing Event-based Studies: Interview with Pantelis Vlachos
The Cytel Trial Design Innovations (CTDI) Webinar Series recently hosted a webinar on designing event-based studies....
Read article

January 22, 2020
What could you accomplish with a fresh approach to your clinical data strategy?
In the quest for clinical success, we all strive for evidence packages of the highest quality. If the clinical data is...
Read article

January 16, 2020
Adaptive Population Enrichment in a Phase III Oncology Trial
January’s Cytel Trial Design Innovations (CTDI) Webinar Series will feature Biostatistician and pioneering Bayesian...
Read article

January 8, 2020
How to optimize your data strategy to drive success in clinical development
In clinical development, data is the vital ‘foundation’ that supports your programs. To successfully bring a promising...
Read article

December 10, 2019
Impact of AI on Clinical Development
In association with Statisticians in the Pharmaceutical Industry (PSI) , UCB and Cytel hosted a symposium on September...
Read article

December 5, 2019
Biotechs and Medtechs, don’t forget your market access strategy (part 4 of 4): How to optimize your market access planning approach
Author: Michael S. Paas, Market Access & Commercialization Expert, Executive at AbbVie and Guest Author at Cytel In...
Read article

December 2, 2019
Biotechs and Medtechs, don’t forget your market access strategy (part 3 of 4): Harnessing the value of market access planning
Author: Michael S. Paas, Market Access & Commercialization Expert, Executive at AbbVie and Guest Author at Cytel...
Read article

November 21, 2019
Biotechs and Medtechs, don’t forget your market access strategy (part 2 of 4): The critical role of market access planning in clinical development
Author: Michael S. Paas, Market Access & Commercialization Expert, Executive at AbbVie and Guest Author at Cytel In my...
Read article

November 14, 2019
Biotechs and Medtechs, don’t forget your market access strategy (part 1of 4): Why is market access strategy crucial to succeed?
Market access strategy is an integral part of the clinical development process to ensure success in global healthcare...
Read article



April 10, 2019
Ensuring Robust ePRO Implementation: Factors for Success
In this blog, Jonathan Pritchard, Director Business Development at Cytel, draws on his experience in commercial,...
Read article


March 26, 2019
How Patient-Reported Outcomes Improve Outcomes
At the Partnerships in Clinical Trials Conference in Barcelona in November 2018, Strategic Consultant Ursula Garczarek...
Read article

January 10, 2019
Podcast: Overcoming Phase 1 Development Challenges
Nand Kishore Rawat is a Director and Head, Early Phase Biostatistics based in the King of Prussia, PA Cytel office. We...
Read article

December 5, 2018
Creating a Common Language: Forging Statistical and Clinical Collaborations
In this blog, Paul Terrill, Director of Strategic Consulting at Cytel outlines his blueprint for ensuring smooth...
Read article


April 3, 2018
Maximizing Preclinical Knowledge for Optimal R&D
By Esha Senchaudhuri In response to its R&D productivity from 2005 – 2010, AstraZeneca took the initiative in 2011 to...
Read article

March 16, 2018
Career Perspectives: Interview with Benjamin Esterni, Principal Biostatistician
At Cytel we believe that expert statistical input has the power to shape the future of clinical development: de-risking...
Read article

October 31, 2017
Webinar Replay: Dual Target Methods for Go/No-Go Decision Making
As part of Cytel's new Trial Innovations Webinar Series, Pat Mitchell, Statistical Science Director at AstraZeneca...
Read article

February 27, 2017
Estimands 101: Interview with Mouna Akacha
It’s been hard to miss the prevalence of estimand-related discussions in the last year. This is a topic which is very...
Read article

October 25, 2016
R Beyond Statistics
Use of R is a hot topic among statisticians and programmers in the pharmaceutical industry. At the recent PhUSE...
Read article
October 13, 2016
The evolving role of the modern statistical programmer
Statistical programmers play a key role in turning the data from clinical trials into knowledge and supporting the...
Read article
September 20, 2016
An efficient tool for model based meta-analysis
Drug development is an expensive and risky business. To maximize a compound’s ultimate chances of commercial as well as...
Read article

June 16, 2016
Determining the future course of your trial
Predicting the course of a clinical trial is something which people will always want to do-whether for statistical...
Read article

June 7, 2016
How can the CMO/Biostatistician connection improve clinical development?
At the recent CMO Summit East James ( Jim) Bolognese, Cytel’s Senior Director of Strategic Consulting, and Lou...
Read article

May 10, 2016
Subgroup Analyses in Early Phase Clinical Trials
We were fortunate to welcome Björn Bornkamp of Novartis to the EUGM 2016 presenting work he has developed jointly with...
Read article

April 5, 2016
What's the price of pharma innovation?
Cost of pharmaceutical development and R&D productivity is an ongoing industry concern, consistently discussed in the...
Read article